A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022 (2023)
Attributed to:
Evidence Synthesis to inform health related decision making
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2807/1560-7917.es.2023.28.36.2300048
PubMed Identifier: 37676146
Publication URI: http://europepmc.org/abstract/MED/37676146
Type: Journal Article/Review
Parent Publication: Eurosurveillance
Issue: 36
ISSN: 1025-496X